Methotrexate pneumonitis precipitated by switching from oral to parenteral administration

被引：7

作者：

Collins, K. ^{[1
]}

Aspey, H. ^{[1
]}

Todd, A. ^{[1
]}

Saravanan, V. ^{[1
]}

Rynne, M. ^{[1
]}

Kelly, C. ^{[1
]}

机构：

[1] Queen Elizabeth Hosp, Birmingham B15 2TH, W Midlands, England

来源：

RHEUMATOLOGY | 2008年 / 47卷 / 01期

关键词：

D O I：

10.1093/rheumatology/kem230

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：109 / 110

页数：3

共 5 条

[1]

[Anonymous], 1999, INTERNAL MED

[2] Adverse reactions to disease-modifying anti-rheumatic drugs in clinical practice [J].

Grove, ML ;

Hassell, AB ;

Hay, EM ;

Shadforth, MF .

QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 2001, 94 (06) :309-319

[3] Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients [J].

Imokawa, S ;

Colby, TV ;

Leslie, KO ;

Helmers, RA .

EUROPEAN RESPIRATORY JOURNAL, 2000, 15 (02) :373-381

[4] The treatment of inflammatory arthritis with methotrexate in clinical practice: treatment duration and incidence of adverse drug reactions [J].

Kinder, AJ ;

Hassell, AB ;

Brand, J ;

Brownfield, A ;

Grove, M ;

Shadforth, MF .

RHEUMATOLOGY, 2005, 44 (01) :61-66

[5] Reducing the risk of methotrexate pneumonitis in rheumatoid arthritis [J].

Saravanan, V ;

Kelly, CA .

RHEUMATOLOGY, 2004, 43 (02) :143-147

← 1 →